Virtus LifeSci Biotech Clinical Trials ETF Rating $23.02 -0.25 (-1.07%) Closing price 01/31/2025 04:10 PM EasternExtended Trading$23.02 +0.00 (+0.00%) As of 01/31/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatings Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.91Holdings in BBC have an aggregate rating of Moderate Buy based on 396 analyst ratings issued in the past year covering 49 companies (46.0% of the portfolio).BBC Aggregate Price Target$23.02High Prediction$23.02Average Prediction$23.02Low Prediction$23.02Holdings in BBC have an aggregate price target of $23.02 and a range of $23.02 to $23.02 covering 49 companies (46.0% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy25 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.49%SANASana Biotechnology$3.22-7.7%3.0145 of 5 stars2.80$14.25 342.5%5Short Interest ↑1.26%VIRVir Biotechnology$10.40+0.9%4.0257 of 5 stars2.83$34.83 234.9%6Analyst ForecastShort Interest ↑Analyst Revision1.22%CVACCureVac$3.79-0.8%4.1316 of 5 stars2.25$10.00 163.9%4Positive News1.11%ORICORIC Pharmaceuticals$10.42-3.2%4.2241 of 5 stars3.00$18.29 75.5%8Positive NewsHigh Trading Volume1.06%LQDALiquidia$14.23-1.2%3.1646 of 5 stars3.11$25.38 78.3%9News Coverage1.05%ARQTArcutis Biotherapeutics$13.24-3.1%2.5409 of 5 stars2.80$16.60 25.4%5Short Interest ↓Positive News1.03%ZYMEZymeworks$14.60-0.9%3.3531 of 5 stars2.86$19.17 31.3%71.01%OMEROmeros$8.62-2.5%4.3784 of 5 stars2.80$22.50 161.0%50.99%TYRATyra Biosciences$14.46-1.7%2.5342 of 5 stars3.00$30.50 110.9%6News Coverage0.98%SRRKScholar Rock$40.380.0%3.1161 of 5 stars3.14$40.43 0.1%7Analyst ForecastNews Coverage0.95%SMMTSummit Therapeutics$21.50-3.8%3.0824 of 5 stars2.86$33.57 56.1%7Positive NewsGap Up0.94%CGONCG Oncology$30.07-0.3%2.2357 of 5 stars3.10$63.88 112.4%10Positive News0.94%XENEXenon Pharmaceuticals$39.98-1.2%2.6259 of 5 stars3.13$56.00 40.1%8Analyst Revision0.93%ABCLAbCellera Biologics$3.17-1.9%2.8537 of 5 stars2.67$8.33 162.9%30.93%ANABAnaptysBio$17.93+2.9%3.8053 of 5 stars2.67$41.45 131.2%120.93%SLNOSoleno Therapeutics$50.23+0.8%4.3811 of 5 stars3.14$74.83 49.0%7Positive News0.93%PCVXVaxcyte$88.32-3.9%2.0572 of 5 stars3.00$145.71 65.0%8News Coverage0.92%PRAXPraxis Precision Medicines$76.55+0.5%2.2322 of 5 stars2.89$149.11 94.8%9Short Interest ↑0.91%COGTCogent Biosciences$9.31-3.2%1.5491 of 5 stars2.57$14.33 54.0%7Short Interest ↑0.91%ITOSiTeos Therapeutics$7.54-1.8%4.113 of 5 stars3.00$22.25 195.1%4Short Interest ↓Positive News0.91%TNGXTango Therapeutics$2.98-4.2%3.1785 of 5 stars3.00$13.14 341.0%8News CoveragePositive News0.91%VERVVerve Therapeutics$7.61+2.7%2.2974 of 5 stars3.00$25.75 238.4%40.90%NUVBNuvation Bio$2.33-3.1%2.3464 of 5 stars3.00$8.20 252.7%5Short Interest ↑0.90%ARCTArcturus Therapeutics$16.97-2.6%2.2748 of 5 stars3.13$61.60 263.0%8Analyst ForecastShort Interest ↑0.90%SNDXSyndax Pharmaceuticals$14.17-0.3%3.6135 of 5 stars2.90$36.20 155.5%10Short Interest ↑0.89%PRTAProthena$14.23-3.2%2.1837 of 5 stars2.71$46.50 226.8%7Analyst RevisionNews Coverage0.89%MRUSMerus$40.94-1.5%3.0554 of 5 stars3.14$85.64 109.2%14Short Interest ↓0.89%KYMRKymera Therapeutics$39.59-2.1%2.5713 of 5 stars2.88$55.06 39.1%170.89%ELVNEnliven Therapeutics$21.86+2.8%2.445 of 5 stars3.20$38.25 75.0%5Positive News0.89%EWTXEdgewise Therapeutics$28.02+0.1%2.1739 of 5 stars2.86$41.29 47.3%7Insider TradeShort Interest ↑Gap Up0.89%PRMEPrime Medicine$2.80-1.1%3.752 of 5 stars3.10$13.13 368.8%10News Coverage0.88%XERSXeris Biopharma$3.56-2.7%3.7282 of 5 stars2.67$4.87 36.7%30.88%VRDNViridian Therapeutics$19.38-3.5%2.5444 of 5 stars2.75$35.70 84.2%12Short Interest ↑Analyst RevisionNews CoveragePositive News0.88%AVBPArriVent BioPharma$28.54-1.9%1.1927 of 5 stars3.00$37.40 31.0%5Short Interest ↑0.88%CAPRCapricor Therapeutics$15.04-1.1%1.9883 of 5 stars3.00$34.50 129.4%60.88%NRIXNurix Therapeutics$19.71-1.5%2.2963 of 5 stars2.94$30.71 55.8%17Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.88%QUREuniQure$15.74-0.3%3.4511 of 5 stars3.00$40.00 154.1%10Analyst RevisionNews Coverage0.88%RNACCartesian Therapeutics$19.31-0.4%2.0759 of 5 stars2.80$42.86 121.9%10Analyst Forecast0.87%NAMSNewAmsterdam Pharma$22.29+2.4%3.1837 of 5 stars3.00$41.60 86.6%6High Trading Volume0.87%MNMDMind Medicine (MindMed)$6.79-4.8%2.2622 of 5 stars3.23$26.33 287.8%13Analyst ForecastAnalyst RevisionNews Coverage0.87%CYTKCytokinetics$49.46-1.0%3.926 of 5 stars2.87$82.79 67.4%150.87%IRONDisc Medicine$55.80+0.4%2.9387 of 5 stars3.10$88.90 59.3%10Short Interest ↑0.86%DNLIDenali Therapeutics$23.30-1.2%4.4692 of 5 stars2.93$38.00 63.1%14Analyst ForecastShort Interest ↑Analyst Revision0.86%PHVSPharvaris$17.60-0.7%2.8224 of 5 stars3.00$40.50 130.1%4Analyst ForecastNews CoveragePositive NewsGap Up0.86%RXRXRecursion Pharmaceuticals$7.24-5.9%2.2266 of 5 stars2.50$8.75 20.9%4Gap Up0.85%EYPTEyePoint Pharmaceuticals$7.65-5.0%1.471 of 5 stars3.00$26.63 248.0%10Short Interest ↑0.85%ANNXAnnexon$3.84-5.0%1.9835 of 5 stars3.00$15.80 311.5%6Short Interest ↑0.85%ALLOAllogene Therapeutics$1.80-6.3%2.8393 of 5 stars2.90$9.73 440.7%100.85%CATXPerspective Therapeutics$3.55-6.8%2.087 of 5 stars2.89$15.14 326.6%9 This page (NYSEARCA:BBC) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
